Uveitis Completed Phase 3 Trials for Methotrexate (DB00563)

Also known as: Unspecified iridocyclitis / Uveitis NOS / Uveitis (disorder)

IndicationStatusPhase
DBCOND0009937 (Uveitis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01829295Methotrexate and Mycophenolate Mofetil for UVEITISTreatment
NCT02623426Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy TrialTreatment
NCT01232920First-line Antimetabolites as Steroid-sparing Treatment Uveitis Pilot TrialTreatment